newsfilter
← Latest News
ACCESS Newswire·

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. , a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on